ID   LBR_HUMAN               Reviewed;         615 AA.
AC   Q14739; B2R5P3; Q14740; Q53GU7; Q59FE6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   31-JAN-2002, sequence version 2.
DT   15-MAR-2017, entry version 171.
DE   RecName: Full=Lamin-B receptor;
DE   AltName: Full=Integral nuclear envelope inner membrane protein;
DE   AltName: Full=LMN2R;
GN   Name=LBR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH DNA; LMNB1 AND LMNB2.
RX   PubMed=8157662;
RA   Ye Q., Worman H.J.;
RT   "Primary structure analysis and lamin B and DNA binding of human LBR,
RT   an integral protein of the nuclear envelope inner membrane.";
RL   J. Biol. Chem. 269:11306-11311(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ASN-154.
RX   PubMed=8157663;
RA   Schuler E., Lin F., Worman H.J.;
RT   "Characterization of the human gene encoding LBR, an integral protein
RT   of the nuclear envelope inner membrane.";
RL   J. Biol. Chem. 269:11312-11317(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASN-154.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASN-154.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASN-154.
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ASN-154.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   SUBUNIT, AND INTERACTION WITH CBX5.
RX   PubMed=9169472; DOI=10.1074/jbc.272.23.14983;
RA   Ye Q., Callebaut I., Pezhman A., Courvalin J.-C., Worman H.J.;
RT   "Domain-specific interactions of human HP1-type chromodomain proteins
RT   and inner nuclear membrane protein LBR.";
RL   J. Biol. Chem. 272:14983-14989(1997).
RN   [9]
RP   PHOSPHORYLATION BY SRPK1.
RX   PubMed=10049757; DOI=10.1006/bbrc.1999.0249;
RA   Papoutsopoulou S., Nikolakaki E., Giannakouros T.;
RT   "SRPK1 and LBR protein kinases show identical substrate
RT   specificities.";
RL   Biochem. Biophys. Res. Commun. 255:602-607(1999).
RN   [10]
RP   FUNCTION.
RX   PubMed=10828963; DOI=10.1021/bi992908b;
RA   Duband-Goulet I., Courvalin J.-C.;
RT   "Inner nuclear membrane protein LBR preferentially interacts with DNA
RT   secondary structures and nucleosomal linker.";
RL   Biochemistry 39:6483-6488(2000).
RN   [11]
RP   DISEASE.
RX   PubMed=12118250; DOI=10.1038/ng925;
RA   Hoffmann K., Dreger C.K., Olins A.L., Olins D.E., Shultz L.D.,
RA   Lucke B., Karl H., Kaps R., Mueller D., Vaya A., Aznar J., Ware R.E.,
RA   Sotelo Cruz N., Lindner T.H., Herrmann H., Reis A., Sperling K.;
RT   "Mutations in the gene encoding the lamin B receptor produce an
RT   altered nuclear morphology in granulocytes (Pelger-Huet anomaly).";
RL   Nat. Genet. 31:410-414(2002).
RN   [12]
RP   INVOLVEMENT IN GRBGD.
RX   PubMed=12618959; DOI=10.1086/373938;
RA   Waterham H.R., Koster J., Mooyer P., van Noort G., Kelley R.I.,
RA   Wilcox W.R., Wanders R.J., Hennekam R.C.M., Oosterwijk J.C.;
RT   "Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3
RT   beta-hydroxysterol delta 14-reductase deficiency due to mutations in
RT   the lamin B receptor gene.";
RL   Am. J. Hum. Genet. 72:1013-1017(2003).
RN   [13]
RP   SUBUNIT, AND INTERACTION WITH CBX5.
RX   PubMed=15882967; DOI=10.1016/j.bbrc.2005.04.016;
RA   Lechner M.S., Schultz D.C., Negorev D., Maul G.G., Rauscher F.J. III;
RT   "The mammalian heterochromatin protein 1 binds diverse nuclear
RT   proteins through a common motif that targets the chromoshadow
RT   domain.";
RL   Biochem. Biophys. Res. Commun. 331:929-937(2005).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-118, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-55; LYS-594 AND LYS-601, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND THR-118, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION AT SER-71 AND SER-86 BY CDK1.
RX   PubMed=21795390; DOI=10.1091/mbc.E11-03-0199;
RA   Tseng L.C., Chen R.H.;
RT   "Temporal control of nuclear envelope assembly by phosphorylation of
RT   lamin B receptor.";
RL   Mol. Biol. Cell 22:3306-3317(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-58; SER-59; SER-128 AND
RP   THR-200, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   STRUCTURE BY NMR OF 1-55.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the Tudor domain of human lamin-B receptor.";
RL   Submitted (SEP-2006) to the PDB data bank.
RN   [25]
RP   STRUCTURE BY NMR OF 1-55.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the Tudor domain of human lamin-B receptor.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [26]
RP   VARIANTS PHA LEU-119 AND ARG-569.
RX   PubMed=14617022; DOI=10.1046/j.1365-2141.2003.04621.x;
RA   Best S., Salvati F., Kallo J., Garner C., Height S., Thein S.L.,
RA   Rees D.C.;
RT   "Lamin B-receptor mutations in Pelger-Huet anomaly.";
RL   Br. J. Haematol. 123:542-544(2003).
RN   [27]
RP   VARIANT REYNS CYS-372.
RX   PubMed=20522425; DOI=10.1136/jmg.2009.071696;
RA   Gaudy-Marqueste C., Roll P., Esteves-Vieira V., Weiller P.J.,
RA   Grob J.J., Cau P., Levy N., De Sandre-Giovannoli A.;
RT   "LBR mutation and nuclear envelope defects in a patient affected with
RT   Reynolds syndrome.";
RL   J. Med. Genet. 47:361-370(2010).
CC   -!- FUNCTION: Anchors the lamina and the heterochromatin to the inner
CC       nuclear membrane. {ECO:0000269|PubMed:10828963}.
CC   -!- SUBUNIT: Interacts directly with CBX5. Can interact with
CC       chromodomain proteins. Interacts directly with DNA. Interaction
CC       with DNA is sequence independent with higher affinity for
CC       supercoiled and relaxed circular DNA than linear DNA.
CC       {ECO:0000269|PubMed:15882967, ECO:0000269|PubMed:8157662,
CC       ECO:0000269|PubMed:9169472}.
CC   -!- INTERACTION:
CC       Q13185:CBX3; NbExp=4; IntAct=EBI-1055147, EBI-78176;
CC       P45973:CBX5; NbExp=4; IntAct=EBI-1055147, EBI-78219;
CC   -!- SUBCELLULAR LOCATION: Nucleus inner membrane; Multi-pass membrane
CC       protein.
CC   -!- DOMAIN: The Tudor domain may not recognize methylation marks, but
CC       rather bind unassembled free histone H3. {ECO:0000250}.
CC   -!- PTM: Phosphorylated by CDK1 in mitosis when the inner nuclear
CC       membrane breaks down into vesicles that dissociate from the lamina
CC       and the chromatin. It is phosphorylated by different protein
CC       kinases in interphase when the membrane is associated with these
CC       structures. Phosphorylation of LBR and HP1 proteins may be
CC       responsible for some of the alterations in chromatin organization
CC       and nuclear structure which occur at various times during the cell
CC       cycle. Phosphorylated by SRPK1. In late anaphase LBR is
CC       dephosphorylated, probably by PP1 and/or PP2A, allowing
CC       reassociation with chromatin. {ECO:0000269|PubMed:10049757,
CC       ECO:0000269|PubMed:21795390}.
CC   -!- DISEASE: Pelger-Huet anomaly (PHA) [MIM:169400]: An autosomal
CC       dominant inherited abnormality of granulocytes, characterized by
CC       abnormal ovoid shape, reduced nuclear segmentation and an
CC       apparently looser chromatin structure. Some individuals
CC       occasionally have skeletal anomalies, developmental delay, and
CC       seizures. {ECO:0000269|PubMed:14617022}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Greenberg dysplasia (GRBGD) [MIM:215140]: A rare
CC       autosomal recessive chondrodystrophy characterized by early in
CC       utero lethality. Affected fetuses typically present with fetal
CC       hydrops, short-limbed dwarfism, and a marked disorganization of
CC       chondro-osseous calcification, and ectopic ossification centers.
CC       {ECO:0000269|PubMed:12618959}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Reynolds syndrome (REYNS) [MIM:613471]: A syndrome
CC       specifically associating limited cutaneous systemic sclerosis and
CC       primary biliary cirrhosis. It is characterized by liver disease,
CC       telangiectasia, abrupt onset of digital paleness or cyanosis in
CC       response to cold exposure or stress (Raynaud phenomenon), and
CC       variable features of scleroderma. The liver disease is
CC       characterized by pruritis, jaundice, hepatomegaly, increased serum
CC       alkaline phosphatase and positive serum mitochondrial
CC       autoantibodies, all consistent with primary biliary cirrhosis.
CC       {ECO:0000269|PubMed:20522425}. Note=The disease may be caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ERG4/ERG24 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92751.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L25931; AAA59494.1; -; mRNA.
DR   EMBL; L25941; AAA59495.1; -; Genomic_DNA.
DR   EMBL; L25932; AAA59495.1; JOINED; Genomic_DNA.
DR   EMBL; L25933; AAA59495.1; JOINED; Genomic_DNA.
DR   EMBL; L25934; AAA59495.1; JOINED; Genomic_DNA.
DR   EMBL; L25935; AAA59495.1; JOINED; Genomic_DNA.
DR   EMBL; L25936; AAA59495.1; JOINED; Genomic_DNA.
DR   EMBL; L25937; AAA59495.1; JOINED; Genomic_DNA.
DR   EMBL; L25938; AAA59495.1; JOINED; Genomic_DNA.
DR   EMBL; L25939; AAA59495.1; JOINED; Genomic_DNA.
DR   EMBL; L25940; AAA59495.1; JOINED; Genomic_DNA.
DR   EMBL; AB209514; BAD92751.1; ALT_INIT; mRNA.
DR   EMBL; AK222834; BAD96554.1; -; mRNA.
DR   EMBL; AK312258; BAG35190.1; -; mRNA.
DR   EMBL; CH471098; EAW69741.1; -; Genomic_DNA.
DR   EMBL; BC020079; AAH20079.1; -; mRNA.
DR   CCDS; CCDS1545.1; -.
DR   PIR; A53616; A53616.
DR   RefSeq; NP_002287.2; NM_002296.3.
DR   RefSeq; NP_919424.1; NM_194442.2.
DR   RefSeq; XP_011542487.1; XM_011544185.2.
DR   UniGene; Hs.435166; -.
DR   UniGene; Hs.735694; -.
DR   PDB; 2DIG; NMR; -; A=1-55.
DR   PDBsum; 2DIG; -.
DR   ProteinModelPortal; Q14739; -.
DR   SMR; Q14739; -.
DR   BioGrid; 110122; 42.
DR   DIP; DIP-5987N; -.
DR   IntAct; Q14739; 21.
DR   MINT; MINT-1631069; -.
DR   STRING; 9606.ENSP00000272163; -.
DR   SwissLipids; SLP:000001239; -.
DR   iPTMnet; Q14739; -.
DR   PhosphoSitePlus; Q14739; -.
DR   SwissPalm; Q14739; -.
DR   BioMuta; LBR; -.
DR   DMDM; 20141468; -.
DR   EPD; Q14739; -.
DR   MaxQB; Q14739; -.
DR   PaxDb; Q14739; -.
DR   PeptideAtlas; Q14739; -.
DR   PRIDE; Q14739; -.
DR   TopDownProteomics; Q14739; -.
DR   DNASU; 3930; -.
DR   Ensembl; ENST00000272163; ENSP00000272163; ENSG00000143815.
DR   Ensembl; ENST00000338179; ENSP00000339883; ENSG00000143815.
DR   GeneID; 3930; -.
DR   KEGG; hsa:3930; -.
DR   UCSC; uc001hoy.4; human.
DR   CTD; 3930; -.
DR   DisGeNET; 3930; -.
DR   GeneCards; LBR; -.
DR   HGNC; HGNC:6518; LBR.
DR   HPA; HPA049840; -.
DR   HPA; HPA062236; -.
DR   MalaCards; LBR; -.
DR   MIM; 169400; phenotype.
DR   MIM; 215140; phenotype.
DR   MIM; 600024; gene.
DR   MIM; 613471; phenotype.
DR   neXtProt; NX_Q14739; -.
DR   OpenTargets; ENSG00000143815; -.
DR   Orphanet; 1426; Greenberg dysplasia.
DR   Orphanet; 779; Reynolds syndrome.
DR   PharmGKB; PA30304; -.
DR   eggNOG; KOG1435; Eukaryota.
DR   eggNOG; ENOG410XP67; LUCA.
DR   GeneTree; ENSGT00390000000417; -.
DR   HOGENOM; HOG000193296; -.
DR   HOVERGEN; HBG007825; -.
DR   InParanoid; Q14739; -.
DR   KO; K19532; -.
DR   OMA; AWEKYCQ; -.
DR   OrthoDB; EOG091G0F22; -.
DR   PhylomeDB; Q14739; -.
DR   TreeFam; TF101179; -.
DR   BioCyc; MetaCyc:HS07110-MONOMER; -.
DR   BRENDA; 1.3.1.70; 2681.
DR   Reactome; R-HSA-191273; Cholesterol biosynthesis.
DR   SIGNOR; Q14739; -.
DR   ChiTaRS; LBR; human.
DR   EvolutionaryTrace; Q14739; -.
DR   GeneWiki; Lamin_B_receptor; -.
DR   GenomeRNAi; 3930; -.
DR   PRO; PR:Q14739; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143815; -.
DR   CleanEx; HS_LBR; -.
DR   ExpressionAtlas; Q14739; baseline and differential.
DR   Genevisible; Q14739; HS.
DR   GO; GO:0016021; C:integral component of membrane; IDA:MGI.
DR   GO; GO:0005639; C:integral component of nuclear inner membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; TAS:Reactome.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0070087; F:chromo shadow domain binding; IPI:BHF-UCL.
DR   GO; GO:0050613; F:delta14-sterol reductase activity; TAS:Reactome.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0005521; F:lamin binding; TAS:ProtInc.
DR   GO; GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome.
DR   GO; GO:0016126; P:sterol biosynthetic process; IBA:GO_Central.
DR   InterPro; IPR001171; Ergosterol_biosynth_ERG4_ERG24.
DR   InterPro; IPR019023; Lamin-B_rcpt_of_tudor.
DR   InterPro; IPR018083; Sterol_reductase_CS.
DR   InterPro; IPR002999; Tudor.
DR   Pfam; PF01222; ERG4_ERG24; 1.
DR   Pfam; PF09465; LBR_tudor; 1.
DR   SMART; SM00333; TUDOR; 1.
DR   PROSITE; PS01017; STEROL_REDUCT_1; 1.
DR   PROSITE; PS01018; STEROL_REDUCT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Disease mutation;
KW   DNA-binding; Membrane; Nucleus; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    615       Lamin-B receptor.
FT                                /FTId=PRO_0000207510.
FT   TOPO_DOM      1    211       Nuclear. {ECO:0000255}.
FT   TRANSMEM    212    232       Helical. {ECO:0000255}.
FT   TRANSMEM    258    278       Helical. {ECO:0000255}.
FT   TRANSMEM    299    319       Helical. {ECO:0000255}.
FT   TRANSMEM    326    346       Helical. {ECO:0000255}.
FT   TRANSMEM    386    406       Helical. {ECO:0000255}.
FT   TRANSMEM    447    467       Helical. {ECO:0000255}.
FT   TRANSMEM    481    501       Helical. {ECO:0000255}.
FT   TRANSMEM    561    581       Helical. {ECO:0000255}.
FT   DOMAIN        1     62       Tudor.
FT   MOD_RES      55     55       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      58     58       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      59     59       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      67     67       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3U9G9}.
FT   MOD_RES      71     71       Phosphoserine; by CDK1.
FT                                {ECO:0000269|PubMed:21795390}.
FT   MOD_RES      86     86       Phosphoserine; by CDK1.
FT                                {ECO:0000269|PubMed:21795390}.
FT   MOD_RES      97     97       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      99     99       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     118    118       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     128    128       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     200    200       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     594    594       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     601    601       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT     119    119       P -> L (in PHA; dbSNP:rs137852605).
FT                                {ECO:0000269|PubMed:14617022}.
FT                                /FTId=VAR_017841.
FT   VARIANT     154    154       S -> N (in dbSNP:rs2230419).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:8157663,
FT                                ECO:0000269|Ref.4, ECO:0000269|Ref.5,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_024318.
FT   VARIANT     169    169       R -> C (in dbSNP:rs2230420).
FT                                /FTId=VAR_052155.
FT   VARIANT     311    311       T -> A (in dbSNP:rs2275601).
FT                                /FTId=VAR_020209.
FT   VARIANT     372    372       R -> C (in REYNS; dbSNP:rs200180113).
FT                                {ECO:0000269|PubMed:20522425}.
FT                                /FTId=VAR_063811.
FT   VARIANT     569    569       P -> R (in PHA; dbSNP:rs137852606).
FT                                {ECO:0000269|PubMed:14617022}.
FT                                /FTId=VAR_017842.
FT   CONFLICT    301    301       A -> P (in Ref. 1; AAA59494).
FT                                {ECO:0000305}.
FT   CONFLICT    452    452       F -> L (in Ref. 5; BAD96554).
FT                                {ECO:0000305}.
FT   CONFLICT    530    530       T -> S (in Ref. 1; AAA59494).
FT                                {ECO:0000305}.
FT   STRAND       11     15       {ECO:0000244|PDB:2DIG}.
FT   TURN         17     19       {ECO:0000244|PDB:2DIG}.
FT   STRAND       22     31       {ECO:0000244|PDB:2DIG}.
FT   TURN         32     35       {ECO:0000244|PDB:2DIG}.
FT   STRAND       36     40       {ECO:0000244|PDB:2DIG}.
FT   STRAND       46     50       {ECO:0000244|PDB:2DIG}.
FT   TURN         51     53       {ECO:0000244|PDB:2DIG}.
SQ   SEQUENCE   615 AA;  70703 MW;  5A7388776F43C66D CRC64;
     MPSRKFADGE VVRGRWPGSS LYYEVEILSH DSTSQLYTVK YKDGTELELK ENDIKPLTSF
     RQRKGGSTSS SPSRRRGSRS RSRSRSPGRP PKSARRSASA SHQADIKEAR REVEVKLTPL
     ILKPFGNSIS RYNGEPEHIE RNDAPHKNTQ EKFSLSQESS YIATQYSLRP RREEVKLKEI
     DSKEEKYVAK ELAVRTFEVT PIRAKDLEFG GVPGVFLIMF GLPVFLFLLL LMCKQKDPSL
     LNFPPPLPAL YELWETRVFG VYLLWFLIQV LFYLLPIGKV VEGTPLIDGR RLKYRLNGFY
     AFILTSAVIG TSLFQGVEFH YVYSHFLQFA LAATVFCVVL SVYLYMRSLK APRNDLSPAS
     SGNAVYDFFI GRELNPRIGT FDLKYFCELR PGLIGWVVIN LVMLLAEMKI QDRAVPSLAM
     ILVNSFQLLY VVDALWNEEA LLTTMDIIHD GFGFMLAFGD LVWVPFIYSF QAFYLVSHPN
     EVSWPMASLI IVLKLCGYVI FRGANSQKNA FRKNPSDPKL AHLKTIHTST GKNLLVSGWW
     GFVRHPNYLG DLIMALAWSL PCGFNHILPY FYIIYFTMLL VHREARDEYH CKKKYGVAWE
     KYCQRVPYRI FPYIY
//
